Peroxide Doai Patents (Class 514/714)
-
Publication number: 20080113037Abstract: Embodiments relate generally to topical compositions useful for treating or preventing a variety of cosmetic conditions and dermatological disorders, where the composition comprises an oxidative pharmaceutical drug and an antioxidant polyhydroxy acid or polyhydroxy lactone. The polyhydroxy acid or polyhydroxy lactone improves the cutaneous effects of the drug. The embodiments further relate to the treatment of a variety of cosmetic conditions and dermatological disorders comprising administering to a subject an effective amount of the composition and to methods of making the compositions.Type: ApplicationFiled: March 5, 2007Publication date: May 15, 2008Inventors: Barbara A. Green, David J. Milora
-
Patent number: 7282202Abstract: An interleukin-6 suppressive agent comprising lactoperoxidase as an active ingredient is used as a pharmaceutical preparation or the like for prevention and/or therapy of a disease caused by production of interleukin-6, such as thrombocytosis, myeloma, Castleman syndrome, rheumatoid arthritis, or influenza-virus infectious disease.Type: GrantFiled: November 25, 2003Date of Patent: October 16, 2007Assignee: Morinaga Milk Industry Co., Ltd.Inventors: Kimiyasu Shiraki, Masahiko Kurokawa, Yoshitaka Tamura, Koji Yamauchi, Hiroyuki Wakabayashi, Kouichirou Shin
-
Patent number: 7153888Abstract: The stabilization of benzoyl peroxide for extended periods of time is disclosed. The stabilized solution contains from between 0.5% and 20% organic peroxide and a stabilizer for preventing degradation of said peroxide in the solution.Type: GrantFiled: December 21, 2004Date of Patent: December 26, 2006Assignee: Alpharx Inc.Inventors: Joseph Schwarz, Michael Weisspapir
-
Patent number: 7060732Abstract: Two separate compositions, one containing an effective anti-acne treating amount of a first active ingredient and one containing a second active ingredient that is incompatible with the first active ingredient are packaged within and dispensed from a common dispenser. By packaging these two active ingredients in this manner, long shelflife and convenient dispensing and application are provided.Type: GrantFiled: April 12, 2002Date of Patent: June 13, 2006Assignee: Imaginative Research Associates, Inc.Inventors: Mohan Vishnupad, Naomi Vishnupad
-
Patent number: 7056536Abstract: A non-corrosive, liquid, aqueous sterilant composition (as a concentrate or ready-to-use solution), which may be provided in two parts which are mixed prior to application, may comprise a peracid (in an equilibrium solution with an underlying carboxylic acid or mixtures of alkyl carboxylic acids and peroxide), inorganic buffering agent, and water. It has been found that the use of this simplified system, even in the absence of additional components which have been thought to be desirable for sterilants used on metal parts (e.g.Type: GrantFiled: March 10, 2003Date of Patent: June 6, 2006Assignee: Ecolab Inc.Inventors: Francis L. Richter, Duane J. Reinhardt, Sally K. Swart
-
Patent number: 6960615Abstract: Topical compositions which include urea and carbamide peroxide are described. Compositions having a pH in the acidic range, particularly in the range of about 2.5 to about 9 are also described. Methods for treating dermatological disorders using the composition are also described.Type: GrantFiled: February 26, 2003Date of Patent: November 1, 2005Assignee: Bradley Pharmaceuticals, Inc.Inventors: Bradley P. Glassman, Dileep Bhagwat, Daniel Glassman
-
Patent number: 6939566Abstract: Microbicidal formulations are described which are preferably ecologically friendly and non-toxic to mammals, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains complexes having the formula R-M, wherein R is at least one organic chelating moiety and M is at least one metal ion which is microbicidal to at least one microorganism. These complexes can disrupt microorganism activities by penetrating the natural protecting bio-films of such microorganisms through the reaction of the R-group with the organic constituents of these microorganisms while releasing M into their intra-cellular media. Thus, this process exhibits its biocidal activities from the inside-out, contrary to other methods which rely on damaging the protective biofilms.Type: GrantFiled: January 17, 2001Date of Patent: September 6, 2005Inventors: Kareem I. Batarseh, Marwan Al-Kayed
-
Patent number: 6884797Abstract: Pharmaceutical formulation, its method of preparation, and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethyl sulfoxide; a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used to treat horses infected with Sarcocystis protozoal infections.Type: GrantFiled: March 30, 2001Date of Patent: April 26, 2005Inventor: Robert F. Hofmann
-
Patent number: 6861075Abstract: A storage-stable biocidal aerated gel composition comprises from 30 to 97% by weight of water, from 0.2 to 5% by weight of a gelling agent selected from xanthan gum, sodium alginate and neutralised carboxyvinyl polymer from 2 to 5% by weight of a fine particulate, hydrophobic silicone-treated silica having a surface area of from 80 to 300 m2/g and from 0.004 to 20% by weight of a biocide which said composition is in the form of fine particles of an aqueous gel containing the water, gelling agent and the biocide, the surfaces of which fine particles are coated with a coating of the finely particulate hydrophobic silica. The biocidal aerated gel composition can be used to control pests using one or more appropriate biocides in the composition.Type: GrantFiled: April 6, 2001Date of Patent: March 1, 2005Assignee: Sorex LimitedInventor: Roland S. Twydell
-
Patent number: 6849276Abstract: The invention concerns a phytosanitary fungicide, bactericidal or bacteriostatic composition comprising at least a mineral salt, a copper oxide or hydroxide suspended in an aqueous emulsion of at least a terpene derivative.Type: GrantFiled: August 24, 1999Date of Patent: February 1, 2005Assignee: Action PinInventors: Ghislain Dufau, Michel Barsacq, Gérard Molla
-
Patent number: 6824794Abstract: A water treatment agent and method of treating water to inhibit, reduce, or prevent the formation of algae and bacteria in a water body. The water treatment agent may include copper sulfate penta-hydrate and/or silver, di-sodium ethylene di-amine tetra-acetic acid dihydrate, a scale inhibitor, a shocking agent and a buffer agent. For instance, the treatment agent may include a composition of copper sulfate pentahydrate, di-sodium ethylene di-amine tetra-acetic acid, monopotassium phosphate or sulfuric acid, and potassium monopersulfate and 1-hydroxyethylidene-1,1-diphosphonic acid.Type: GrantFiled: May 31, 2002Date of Patent: November 30, 2004Assignee: Innovative Water Technologies, Inc.Inventors: Terry A. Ring, Tom Smolkov, M. Anthony Gamarra
-
Patent number: 6814984Abstract: The present invention is directed to frozen biocidal compositions. Specifically, the biocidal compositions comprise a frozen aqueous solution of a plurality of ions selected from the group consisting of halide and oxyhalide ions. The frozen biocidal compositions are useful in preserving or extending the shelf-life of perishable articles.Type: GrantFiled: February 8, 2002Date of Patent: November 9, 2004Assignee: Clean Water International LLCInventors: David C. Rose, Lawrence J. Ventura
-
Patent number: 6790463Abstract: The use of a pharmaceutical formulation in treating coronary arteriosclerosis and a two-component pharmaceutical formulation. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimithyl sulfoxide; a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone.Type: GrantFiled: March 30, 2001Date of Patent: September 14, 2004Inventors: Robert F. Hofmann, Robert H. Carpenter
-
Patent number: 6673374Abstract: This application relates to a pharmaceutical composition and methods for treating inflammatory skin conditions. The compositions include hydrogen peroxide, one or more moisturizing agents, and an anti-inflammatory agent. The pharmaceutical compositions may optionally include one or more exfoliants. The compositions can be used to treat inflammatory skin conditions such as dermatitis, including, but not limited to seborrheic dermatitis, nummular dermatitis, contact dermatitis, atopic dermatitis, exfoliative dermatitis, perioral dermatitis, and stasis dermatitis; psoriasis; folliculitis; rosacea; acne; impetigo; erysipelas; paronychia, erythrasma; and eczema.Type: GrantFiled: September 17, 2001Date of Patent: January 6, 2004Inventor: Howard Murad
-
Patent number: 6663902Abstract: The present invention relates to a biocidal composition, designed for the generation of chlorine dioxide, comprising at least one iodo-compound having at least one iodine atom and a source of chlorite ions. The molar ration of chlorite ions to iodine atoms is 2 or greater. The composition finds use in a variety of applications including methods of cleaning, sanitizing, deodorizing, and disinfecting various surfaces.Type: GrantFiled: September 19, 2000Date of Patent: December 16, 2003Assignee: Ecolab Inc.Inventors: Robert D. P. Hei, David Daniel McSherry, Kim R. Smith, Keith E. Olson
-
Patent number: 6663874Abstract: A composition for use by animals, including humans, to alleviate pain and/or inflammation around a painful joint, joint replacement surgery site, muscle, tendon, and/or ligament. A method to ameliorate pain and/or inflammation in or around a joint, muscle, tendon, and/or ligament, by topically applying Applicant's composition.Type: GrantFiled: January 19, 2001Date of Patent: December 16, 2003Inventor: Victor Stevens
-
Patent number: 6613311Abstract: A composition for use in bleaching hair in combination with a liquid peroxide based oxidizing agent, said composition comprising an effective amount of at least one persulfate salt dispersed in a silicone oil base and a method for bleaching hair with said composition.Type: GrantFiled: February 1, 2001Date of Patent: September 2, 2003Assignee: Revlon Consumer Products CorporationInventor: Teresita Vargaria Imperial
-
Patent number: 6589565Abstract: A non-corrosive, liquid, aqueous sterilant composition (as a concentrate or ready-to-use solution), which may be provided in two parts which are mixed prior to application, may comprise a peracid (in an equilibrium solution with an underlying carboxylic acid or mixtures of alkyl carboxylic acids and peroxide), inorganic buffering agent, and water. It has been found that the use of this simplified system, even in the absence of additional components which have been thought to be desirable for sterilants used on metal parts (e.g.Type: GrantFiled: November 22, 1999Date of Patent: July 8, 2003Assignee: Ecolab Inc.Inventors: Francis L. Richter, Duane J. Reinhardt, Sally K. Swart
-
Patent number: 6582683Abstract: Disclosed is a dermal barrier composition which contains a hydrophilic polymer emulsion and a hydrophobic polymer emulsion. The dermal barrier composition is moisture activated, and remains inert until the hydrophobic and hydrophilic polymer emulsions contact a suitable substrate such as human skin. The dermal barrier composition is itself an emulsion, and can optionally contain a biocidal agent for antimicrobial and antiviral efficacy. The dermal barrier composition can also contain other active agents such as sunscreens, insect repellents and fungicides. The dermal barrier composition can be applied topically to skin, where it forms a protective or barrier layer against a number of pathogenic and chemical irritants.Type: GrantFiled: January 4, 2000Date of Patent: June 24, 2003Assignee: Skinvisible Pharmaceuticals, Inc.Inventor: Bruce Jezior
-
Patent number: 6573301Abstract: Topical compositions which include urea and carbamide peroxide are described. Compositions having a pH in the acidic range, particularly in the range of about 2.5 to about 9 are also described. Methods for treating dermatological disorders using the composition are also described.Type: GrantFiled: April 23, 2002Date of Patent: June 3, 2003Assignee: Bradley Pharmaceuticals, Inc.Inventors: Bradley P. Glassman, Dileep Bhagwat, Daniel Glassman
-
Publication number: 20030032677Abstract: Pharmaceutical formulation, its method of preparation, and its use. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimethyl sulfoxide; a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone. The pharmaceutical formulation is used to treat horses infected with Sarcocystis protozoal infections.Type: ApplicationFiled: March 30, 2001Publication date: February 13, 2003Inventor: Robert F. Hofmann
-
Patent number: 6518318Abstract: Enhanced muscle performance, including strength, recovery and endurance can be achieved by means of improved glucose transport and improved glycogen loading within animal muscle tissue through the administration of an effective amount of a pinitol compound. Pinitol alone, or in combination with a synergistic amount of insulin, is effective for controlling insulin-dependent diabetes.Type: GrantFiled: May 30, 2001Date of Patent: February 11, 2003Inventor: Charles E. Weeks
-
Patent number: 6514509Abstract: A method for preparing a disinfectant and sterilizing peracetic acid solution, comprising the production just before use of peracetic acid by mixing an activator (HP) with a parent mixture.Type: GrantFiled: April 22, 1999Date of Patent: February 4, 2003Assignee: Farmec S.n.c. di Tabasso Renato & C.Inventor: Renato Tabasso
-
Patent number: 6506737Abstract: An oxidizing species is described herein as a reaction product through an in situ preparation combining a protonizable phosphorus or sulfur compound, and a halide source at controlled proportions in an aqueous, non-aqueous, gel, aerosol, solid-phase or powdered media. The oxidizing species can be used to reduce microbial and viral populations on a surface or object or in a body or stream of water. The invention thus finds applications as a bleach, sanitizer, oxidant, or in any other application in which an oxidizing agent can be beneficially used alone or in a formulation.Type: GrantFiled: April 5, 2000Date of Patent: January 14, 2003Assignee: Ecolab, Inc.Inventors: Robert D. P. Hei, Kim Smith
-
Patent number: 6506416Abstract: The present invention provides a virucide composition and/or sporicide composition having a high virucidal effect and sporicidal effect and being excellent in safety and workability. That is, the present invention provides a virucide composition and/or sporicide composition comprising (a) an inorganic peroxide, (b) tetraacetylethylenediamine and (c) at least one selected from a salt of an alkaline metal salt with an inorganic acid and a salt of an alkaline earth metal with an inorganic acid in a specific ratio.Type: GrantFiled: June 30, 2000Date of Patent: January 14, 2003Assignee: Kao CorporationInventors: Yuji Okauchi, Tadashi Moriyama, Hiroyoshi Hiramatsu, Yuichi Hioki
-
Patent number: 6506417Abstract: A disinfectant composition is disclosed effective against a pathovar of Xanthomonas axonopodis pathogenic for citrus, comprising an aqueous solution of a carboxylic acid, hydrogen peroxide, and a percarboxylic acid product thereof. In a preferred composition the percarboxylic acid comprises peroxyacetic acid in an equilibrium aqueous solution with hydrogen peroxide, and acetic acid. The composition is used in a process to disinfect citrus fruit and equipment used therewith by contacting with a sufficient concentration of the composition for a sufficient time for reducing the organisms by at least 99.9%.Type: GrantFiled: June 28, 2001Date of Patent: January 14, 2003Assignee: FMC Technologies, Inc.Inventor: John M. Siddle
-
Patent number: 6500465Abstract: The present invention relates to a volatile, residue free peroxide antimicrobial composition, which can be applied as a penetrating and durable, fine aerosol, that has superior strength with respect to decontaminating buildings infected with bacteria, fungi, virus or fungal or bacterial spores. The present invention is also directed to a process for decontaminating large man made structures and the air contained in these.Type: GrantFiled: March 4, 2002Date of Patent: December 31, 2002Inventor: Alvin Ronlan
-
Publication number: 20020177585Abstract: The use of a pharmaceutical formulation in treating coronary arteriosclerosis and a two-component pharmaceutical formulation. The pharmaceutical formulation contains peroxidic species or reaction products resulting from oxidation of an alkene, such as geraniol, by an oxygen-containing oxidizing agent, such as ozone; a penetrating solvent, such as dimithyl sulfoxide; a dye containing a chelated metal, such as hematoporphyrin; and an aromatic redox compound, such as benzoquinone.Type: ApplicationFiled: March 30, 2001Publication date: November 28, 2002Inventors: Robert F. Hofmann, Robert H. Carpenter
-
Patent number: 6486211Abstract: Novel indole derivatives, pharmaceutical compositions containing these compounds and their use as inhibitors of the fatty acid synthase FabH are disclosed.Type: GrantFiled: April 2, 2002Date of Patent: November 26, 2002Assignee: SmithKline Beecham CorporationInventors: Robert A. Daines, William Dennis Kingsbury, Israil Pendrak
-
Patent number: 6462025Abstract: Two separate compositions, one containing an antibiotic and one containing benzoyl peroxide are packaged within and dispensed from a common dispenser. More particularly, a dual dispenser contains i) a first composition that is substantially anhydrous and includes a polar solvent, an antibiotic and a thickening agent selected from the group consisting of acrylic acid polymers and polyacrylamides; and ii) a second composition containing benzoyl peroxide or, alternatively, a retinoid. By packaging these two anti-acne active ingredients in this manner, long shelflife and convenient dispensing and application are provided.Type: GrantFiled: December 12, 2000Date of Patent: October 8, 2002Assignee: Imaginative Research Associates, Inc.Inventor: Mohan Vishnupad
-
Patent number: 6448233Abstract: Disclosed herein is a dispensing system for benzoyl chloride and an antimicrobial agent which antimicrobial agent is a macrolide or an aminoglycoside antibiotic. The dispensing system comprises a first container containing a composition comprising benzoyl peroxide suspended in an aqueous solvent and further includes a viscosifying agent and a second container containing a second composition, wherein the second composition comprises an antimicrobial agent in a solvent and further comprising a viscosifying agent. The solvent is present in a concentration which is too high for direct application.Type: GrantFiled: March 21, 2000Date of Patent: September 10, 2002Assignee: Cosmoferm B.V.Inventors: Jean Marie Lefevre, Luppo Edens
-
Patent number: 6433024Abstract: The present invention is directed towards a topical composition for the treatment of acne comprising water, an organic peroxide, an alpha hydroxy acid, a moisturizer, an isosorbide and a detergent. This invention also is directed to a method of making the composition of this invention. The method involves (1) heating water to between 60° C. and 70° C.; (2) adding a detergent base to the water and mixing the solution; (3) cooling the solution and adding an alpha hydroxy acid, an isosorbide and sodium pyrollidone carboxylate; (4) continuing to cool the solution to between 25° C. and 35° C. and then adding benzoyl peroxide and a preservative to the solution; (5) mixing and milling the product until smooth; and (6) adjusting the pH of the product to a pH of 3-5 with a base. This invention also is directed towards a method for treating a patient afflicted with acne by applying the composition of this invention to the affected areas of the patient's skin.Type: GrantFiled: May 8, 2000Date of Patent: August 13, 2002Inventors: Karl F. Popp, Brent D. Stiefel
-
Patent number: 6406682Abstract: Human skin is artificially tanned, darkened and/or browned by topically applying thereto, for such period of time as required to elicit the desired response, an effective self-tanning/coloring amount of at least one plant of the genus Saxifraga, advantageously in association with a thus-effective amount of another skin colorant, e.g., dihydroxyacetone (“DHA”).Type: GrantFiled: June 30, 2000Date of Patent: June 18, 2002Assignee: Societe L'OrealInventors: Richard Martin, Béatrice Belcour-Castro, Cédric Galup
-
Patent number: 6391923Abstract: The present invention relates to aqueous dispersions preparable by polymerization of an olefinically unsaturated, water-insoluble compound in the presence of a water-soluble allyl or vinyl ether of the formula 1 in which b is 0 or 1 n is 0 or 1 k is an integer from 1 to 20, X is O or N[(A—O)m—R] A is C2-C4-alkylene m is an integer from 5 to 900, and R is H or C1-C4-alkyl, and in which A is not exclusively C3- or C4-alkylene, by mixing the olefinically unsaturated water-insoluble compound with the water-soluble allyl and vinyl ether in water, and triggering the polymerization by a free-radical initiator.Type: GrantFiled: July 13, 2000Date of Patent: May 21, 2002Assignee: Clariant GmbHInventors: Klaus Pöllmann, Hendrik Ahrens, Achim Stankowiak
-
Publication number: 20020039599Abstract: Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed.Type: ApplicationFiled: April 17, 2001Publication date: April 4, 2002Inventors: Henry C. Lin, Mark Pimentel
-
Publication number: 20020004057Abstract: A method for preparing a disinfectant and sterilizing peracetic acid solution, comprising the production just before use of peracetic acid by mixing an activator (HP) with a parent mixture.Type: ApplicationFiled: April 22, 1999Publication date: January 10, 2002Inventor: RENATO TABASSO
-
Patent number: 6326032Abstract: A peroxyacid antimicrobial concentrate and use composition is provided comprising a C1 to C4 peroxycarboxylic acid or a C1 to C4 peroxycarboxylic acid combined with a C6 to C18 peroxyacid in beverage processing. The combination of these materials produces a synergistic effect, providing a much more potent biocide than can be obtained by using these components separately. Other components can be added to the composition such as hydrotrope coupling agents, stabilizers, etc. An effective antimicrobial use solution is formed at low concentrations when the concentrate composition is diluted with water to a pH in the range of about 2 to 8. Sanitizing of substantially fixed, “in-place” processing lines in dairies, breweries, and other food and beverage processing operations is one utility of the composition. Another utility is in processes including aseptic cold filling of beverage containers such as cans, glass bottles or two liter PET bottles.Type: GrantFiled: November 18, 1998Date of Patent: December 4, 2001Assignee: Ecolab Inc.Inventors: Francis L. Richter, Bruce R. Cords, Michael E. Besse, Kenji Nogami
-
Patent number: 6309654Abstract: The present invention pertains to the use of a cosmetically and dermatologically well-tolerated organic compound containing activated oxygen for preparing a preparation for improving the microcirculation of the skin.Type: GrantFiled: April 22, 1999Date of Patent: October 30, 2001Assignee: Gabriele Wyeth Ohg Kosmetik BerlinInventors: Wolf-Dieter Hörner, Klaus Gäbelein
-
Patent number: 6262117Abstract: The present invention provides a method for treating acne vulgaris by serially applying a topical composition of azelaic acid and a topical composition of benzoyl peroxide. The present invention also provides topical compositions of a peroxide of benzoyl peroxide, and azelaic acid and its derivatives, such as azelaic acid, sodium salt or methylester which are useful for treating acne vulgaris and may be used to simultaneously apply benzoyl peroxide and azelaic acid.Type: GrantFiled: February 18, 1999Date of Patent: July 17, 2001Assignee: Allergan Sales, Inc.Inventor: John Sefton
-
Patent number: 6242009Abstract: Microbicidal formulations are described which are preferably ecologically friendly and non-toxic to mammals, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains complexes having the formula R-M, wherein R is at least one organic chelating moiety and M is at least one metal ion which is microbicidal to at least one microorganism. These complexes can disrupt microorganism activities by penetrating the natural protecting bio-films of such microorganisms through the reaction of the R-group with the organic constituents of these microorganisms while releasing M into their intra-cellular media. Thus, this process exhibits its biocidal activities from the inside-out, contrary to other methods which rely on damaging the protective biofilms.Type: GrantFiled: April 20, 1999Date of Patent: June 5, 2001Inventors: Kareem I. Batarseh, Marwan Al-Kayed
-
Patent number: 6211213Abstract: Stable microbicidal compositions containing a 3-isothiazolone compound, organic oxidants, copper salts and water are disclosed. Also disclosed are methods of stabilizing 3-isothiazolone compositions.Type: GrantFiled: April 12, 2000Date of Patent: April 3, 2001Assignee: Rohm and Haas CompanyInventor: Beverly Jean El A'mma
-
Patent number: 6200551Abstract: A treatment for xerostomia, employing a composition having the active ingredient of carbamide peroxide. The carbamide peroxide compound contains urea and hydrogen peroxide. The hydrogen peroxide remains stable until the carbamide peroxide is applied to the mouth and contacts the water inherent therein. On contact, the hydrogen peroxide is freed from the urea, allowing the hydrogen peroxide to react within the mouth. The resulting chemical and mechanical reaction stimulates saliva within the mouth and thereby relieves the symptoms of xerostomia.Type: GrantFiled: January 27, 2000Date of Patent: March 13, 2001Inventor: Susan Ann Morgan
-
Patent number: 6117843Abstract: A pharmaceutical composition containing clindamycin and benzoyl peroxide is disclosed for the treatment of acne. The composition is stable for several months when stored at room temperature. Methods of preparing and of using the composition are disclosed.Type: GrantFiled: May 13, 1997Date of Patent: September 12, 2000Assignees: Lloyd J. Baroody, Gordon J. DowInventors: Lloyd J. Baroody, Gordon J. Dow, Debra A. Dow, Robert Lathrop
-
Patent number: 6114398Abstract: A composition is formed of chlorine dioxide and a phosphate added to a mixture of glucono delta lactone, glycerin and hydroxyethyl cellulose to form a lubricant that will stop itching by killing Candida species and several other organisms known to colonize the vagina.Type: GrantFiled: March 2, 1999Date of Patent: September 5, 2000Inventor: Perry A. Ratcliff
-
Patent number: 6080417Abstract: The invention concerns a hand disinfectant based on lower alcohols and is characterized by an aqueous solution of lower alcohols with synergists, the solution having a flash point of more than 21.degree. C.Type: GrantFiled: August 31, 1998Date of Patent: June 27, 2000Assignee: Antiseptica Chemisch-Pharmazeutische Produkte GmbHInventors: Axel Kramer, Leopold Dohner
-
Patent number: 6013637Abstract: Compositions and methods for the treatment of acne including a peroxide and an antibiotic from the lincomycin family of antibiotics are disclosed.Type: GrantFiled: June 12, 1998Date of Patent: January 11, 2000Assignee: Dermik Laboratories Inc.Inventors: Robert W. Klein, Albert M. Packman
-
Patent number: 5958984Abstract: Compositions and processes for medicating human skin disorders using hydrogen peroxide as an active antimicrobial agent. The composition includes essentially hydrogen peroxide, a non-volatile carrier-solvent, and water. A predetermined final hydrogen peroxide concentration is achieved through evaporation of water. In this manner, hydrogen peroxide concentration may be controlled to avoid deleterious effects. Other therapeutic agents such as alpha hydroxy acids may also be added to the composition for treating various skin ailments.Type: GrantFiled: January 21, 1998Date of Patent: September 28, 1999Inventor: Richard L. Devillez
-
Patent number: 5916568Abstract: A flash-dry disinfectant composition for use as a hand wash is described. The composition consists of a C.sub.2 -C.sub.5 alcohol, a hydrogen peroxide solution and a bacteriostatic skin emollient. The C.sub.2 -C.sub.5 alcohol is preferably isopropanol. The composition contains at least about 15% to about 35% by weight of hydrogen peroxide solution in order to ensure a bacteriacidal effect with short term exposure to the composition. The composition has broad application in the food and health care industries. The advantage is a flash-dry disinfectant which may be used in place of lengthy scrub procedures effectively destroying bacteria without known risk of evolutionary resistance and which requires no towels or associated paraphernalia.Type: GrantFiled: November 9, 1998Date of Patent: June 29, 1999Inventors: Teresa A. Smyth, Dennis R. Lambert
-
Patent number: 5912255Abstract: A pharmaceutical composition of all fluoroquinolones, including but not limited to, ciprofloxacin, ofloxacin, enoxacin, cinoxacin, pefloxacin, lomefloxacin, norfloxacin, tosufloxacin, fleroxacin, temafloxacin, trovafloxacin, and difloxacin, mixed with benzoyl peroxide in a vehicle for the topical treatment of a variety of skin conditions. The topical antibiotic and peeling agent will be in the form of a cream, ointment, lotion, gel, suspension, emulsion, cleansing bar, pledget, salve, tincture, spray, transdermal device, or other appropriate non-toxic pharmaceutical carrier.Type: GrantFiled: February 27, 1998Date of Patent: June 15, 1999Inventor: Letantia Bussell
-
Patent number: 5869062Abstract: An improved skin treatment composition is provided. The composition comprises calamine in an amount between about 8% and 20%, an antioxidant in an amount between about 0.05 and 3 weight percent; and an herbal anti-bacterial substance in an amount between about 0.25 and 4 weight percent. These ingredients are combined with a base, preferably comprised of water and glycerin, in order to prepare the inventive composition. The base will generally comprise from between 25% and 60% by weight of the overall composition.Type: GrantFiled: May 27, 1997Date of Patent: February 9, 1999Inventor: Benjamin Oliver